Somatomedin in cord blood: relationship to gestational age and birth size.
Somatomedin (SM) was determined by bioassay in cord blood from 100 neonates born at 24-42 weeks of gestation and from three infants with major congenital malformations. SM levels rose with gestational age and had a positive correlation with birth weight, length and head circumference independantly of gestational age. These findings suggest a relationship between somatomedin and fetal growth.
D001724:Birth Weight; D000013:Congenital Abnormalities / Q000097:blood; D005260:Female; D005312:Fetal Blood / Q000032:analysis*; D005333:Fetus / Q000502:physiology*; D005865:Gestational Age; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D007231:Infant, Newborn; D007236:Infant, Small for Gestational Age; D007328:Insulin / Q000097:blood; D011247:Pregnancy; D013002:Somatomedins / Q000097:blood* / Q000502:physiology
D007328:Insulin; D013002:Somatomedins; D013006:Growth Hormone